Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Authors

  • Pisa Phiphitaporn Department of Internal Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand

Keywords:

-

Downloads

Download data is not yet available.

Downloads

Published

2022-06-27

Issue

Vol. 32 No. 2: April-June 2022

Section

ย่อวารสาร (Journal Club)

License

Copyright (c) 2022 Journal of Hematology and Transfusion Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.